Skip to search formSkip to main contentSkip to account menu

drug development

Known as: development drug, development drugs 
Design, identification, synthesis, extraction, purification, modification, or characterization of potential anticancer agents; studies of their… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs).
Review
2008
Review
2008
Human embryonic stem cells: current technologies and emerging industrial applications.
Review
2006
Review
2006
Metabonomic modeling of drug toxicity.
Highly Cited
2005
Highly Cited
2005
HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk.
Highly Cited
2005
Highly Cited
2005
Orthogonal method development using hydrophilic interaction chromatography and reversed-phase high-performance liquid chromatography for the determination of pharmaceuticals and impurities.
Highly Cited
2003
Highly Cited
2003
Identification of a high-affinity phosphopeptide inhibitor of Stat3.
Review
2003
Review
2003
Molecular diversity through sugar scaffolds.
Highly Cited
2000
Highly Cited
2000
Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization
Pharmacokinetic and pharmacodynamic analyses conducted during the development of docetaxel showed that patients with non–small… 
Review
1999
Review
1999
Enzymes of parasite thiol metabolism as drug targets.
Review
1989
Review
1989
Antitumor and antiviral substances from fungi.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)